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Abstract
Background: Iron has an integral role in numerous cellular reactions and is required by virtually all organisms. In
physiological conditions, iron is abundant in a largely insoluble ferric state. Ferric reductases are an essential component of
iron uptake by cells, reducing iron to the soluble ferrous form. Cytochromes b561 (cyts-b561) are a family of ascorbate
reducing transmembrane proteins found in most eukaryotic cells. The identification of the ferric reductase duodenal
cytochrome b (dcytb) and recent observations that other cyts-b561 may be involved in iron metabolism have opened novel
perspectives for elucidating their physiological function.
Methodology/Principal Findings: Here we have identified a new member of the cytochrome b561 (Sjcytb561) family in the
pathogenic blood fluke Schistosoma japonicum that localises to the outer surface of this parasitic trematode. Heterologous
expression of recombinant Sjcyt-b561 in a Saccharomyces cerevisiae mutant strain that lacks plasma membrane
ferrireductase activity demonstrated that the molecule could rescue ferric reductase activity in the yeast.
Significance/Conclusions: This finding of a new member of the cytochrome b561 family further supports the notion that a
ferric reductase function is likely for other members of this protein family. Additionally, the localisation of Sjcytb561 in the
surface epithelium of these blood-dwelling schistosomes contributes further to our knowledge concerning nutrient
acquisition in these parasites and may provide novel targets for therapeutic intervention.
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Introduction
Iron is an essential co-factor of many biological processes in
nearly all organisms, and serves as a major strengthening and
stabilizing metal in invertebrates [1]. Although iron is the second
most abundant element on Earth and the fourth most abundant
element in the crust, it exists in inorganic form, most often as
insoluble trivalent ferric hydroxide or ferric oxide salts, forms that
are not readily bio-available to organisms [2]. In mammalian
tissues, iron is predominantly stored or transported by an array of
molecules, including organic chelates, the serum transporter
transferrin, or in the cytoplasmic storage complex ferritin, in its
ferric form [3,4]. However, it is in the divalent, or ferrous, state
that iron participates as a co-factor in biological processes.
Accordingly, it is necessary for cells to be able to reduce and
solubilise iron in order to use it for a variety of cellular functions.
Early studies showed that eukaryotes acquire iron from their
environment more readily as a ferrous ion. In yeast, chelators of
ferric iron do not inhibit transmembrane iron transport and
uptake, whereas ferrous chelators do [2,5]. This biological
characteristic has led to the identification and functional
characterization of many ferric reductases, molecules able to
convert ferric to ferrous iron, from a wide range of organisms,
most notably the well studied FRE family of metalloreductases of
yeast and the ferric reductase oxidase (FRO) proteins of plants
[6,7,8,9,10,11,12,13]. In mammals, the two major ferric reductase
families that have been characterised include the cytochrome b561
homologues, among which the duodenal cytochrome b (Dcytb) is
known most prominently, and the Steap family of metalloreduc-
tases [4,10,14,15].
Schistosomes, platyhelminth parasites of humans, and other
mammals, are a major source of human morbidity in many
developing countries in tropical areas [16]. Adult schistosomes live
within the vasculature of their human hosts and feed predomi-
nantly on erythrocytes, which are ingested, lysed and digested in a
primitive gut, the gastrodermis. Females, in particular, have high
metabolic requirements for iron, which is stored in abundance in
vitelline, or egg shell precursor cells, to be used subsequently for
embryogenesis, where it is thought to assist in stabilization of
protein cross-links in the tanned eggshells [17,18]. In addition to
this choriogenic requirement, schistosomes also depend on iron for
early establishment and growth in the human host [19]. In view of
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the importance of iron in the development of schistosomes, there
has been growing interest in understanding how they acquire iron
in their parasitic environment as a means to discovering new drug
and vaccine targets for their control [20].
The surface of schistosomes consists of a syncytial anucleate layer,
known as the tegument. This cytoplasmic layer serves as a nutritive
and protective surface, and acts in immune evasion and, possibly,
signalling for parasite development [21,22]. A surface-associated
pathway for iron absorption has been postulated for schistosomes
[19,20]. This hypothesis is supported by recent functional analysis of
the membrane spanning divalent metal transporter (DMT1) family
of proteins in Schistosoma mansoni [23]. The schistosome DMT1s,
which show a tegumentary distribution by immunofluorescence
microscopy, have been demonstrated to transport ferrous iron when
expressed heterologously in yeast [23]. The presence of a
membrane-spanning protein in schistosomes that transports ferrous
iron into cells thus suggests that these blood-dwelling parasites must,
of necessity, express molecules with ferric reductase activity [20]. To
date, however, no functional ferric reductase has been characterised
in schistosomes, or any other helminth.
One family of proteins recently identified as having ferric reductase
capability are the cytochromes b561. These are intrinsic membrane
proteins, containing two heme molecules, and are considered to be
reducible by ascorbate [24]. Initially thought as only electron
transporters [25], b561 family members were shown to have ferric
reductase capacity following functional characterization of a
mammalian duodenal cytb561 (dcytb) [26,27,28,29]. Expressed
sequence tags of putative cytb561 family members have been shown
to be present in the genomes of S. japonicum [15,30,31] and S. mansoni
[32,33]. Here we describe the identification and molecular
characterisation of a protein of the cytb561 family (Sjcytb561) from
S. japonicum and demonstrate that it has functional ferric reductase
activity and occurs in the tegument of these blood-dwelling parasites.
Materials and Methods
The use of mice in this study was approved under Project P288
by the Animal Ethics Committee of the Queensland Institute of
Medical Research.
Isolation of RNA from schistosomes
Oncomelania hupensis hupensis snails, infected with a Chinese
mainland strain of S. japonicum (Anhui Province population), were
kindly provided by the National Institute of Parasitic Diseases-
CDC, Shanghai, China. Adult worms were perfused from BALB/
c mice 4 or 7 weeks after cutaneous infection with 30 S. japonicum
cercariae. Eggs were collected following their extraction from the
livers of infected mice by digestion of liver matrix by collagenase B
and differential centrifugation using Percoll [34]. Miracidia were
hatched from eggs by exposure to freshwater. The human-invasive
cercariae were harvested from infected O. h. hupensis snails that
were shed by exposure to direct light for approximately 2 h. Lung
schistosomula were isolated from infected mice using a previously
published procedure [35]. Approximately 1,000 cercariae were
pooled from several infected O. h. hupensis snails, and used to
challenge female BALB/c mice. Three days later the lungs were
removed, minced with a razor blade and incubated in RPMI at
37uC for 3 h on a shaker. The lung tissue solution was sieved and
schistosomula removed using a fine tipped glass pipette. Total
RNA was obtained from the five different life stages by
homogenizing parasite tissue in Trizol (Invitrogen) according to
the manufacturer’s instructions.
Full length cDNA synthesis by RACE PCR
Expressed sequence tags (EST) encoding schistosome cytb561
were first identified by BLAST searches of the S. mansoni and S.
japonicum EST databases. The GeneRacer kit (Invitrogen) was used
for full length Rapid Amplification of 59 and 39 ends (RACE).
Total RNA from adult worms was used and cDNA synthesis was
carried out following the GeneRacer protocol. Numerous primers
were designed based on ESTs and used in conjunction with
proprietary GeneRacer 59 and 39 universal primers to amplify the
full-length Sjcytb561 sequence. This cDNA was amplified using
Platinum taq DNA polymerase High Fidelity (Invitrogen), with the
following cycling parameters: initiation at 96uC for 5 min, and 35
cycles of denaturation (94uC for 1 min), annealing (50uC for
1 min) and extension (68uC for 2 min).
Stage-specific expression of Sjcdytb561
Transcriptional patterns for the different S. japonicum life- stages
were evaluated using real time PCR. Primers were designed to
amplify sequences for Sjcytb561 (forward: 59-TGGACCAATG-
CAAACACAGT-39; reverse: 59-TGATTCCCAGGACACCAA-
AT-39) and a region of S. japonicum NADH ubiquinone reductase
(forward: 59-CGAGGACCTAACAGCAGAGG-39; reverse: 59-
TCCGAACGAACTTTGAATCC-39), used as a constitutively
expressed control as previously described [35,36]. All cDNA
samples synthesised from total RNA were adjusted to 5 ng/mL,
and quantified using a NanoDrop ND-1000 spectrophotometer
(Thermo Scientific). Five mL aliquots of cDNA were then
combined with 10 mL of SYBER Green (Applied Biosystems),
3 mL of water and 2 mL (5 pmol) of each forward and reverse
primer in a Gene-Disc 100 ring (Qiagen) using a CAS-1200
automated PCR setup robot (Qiagen). Cycling conditions were: 10
minutes at 93uC followed by 40 cycles of 93uC for 20 seconds,
60uC for 15 seconds and 72uC for 15 seconds. All reactions were
performed in a Rotor-Gene (3000) thermal cycler (Qiagen) and the
data analysed using Rotor Gene 6 software (Qiagen). A standard
curve was created with a mixed template (contained 50 mL from
each separate template) and the mean copies per reaction values
were calculated from the mean of 3 normalised CT (cycle
threshold) values. All PCR experiments were conducted in
triplicate.
Author Summary
Parasites acquire their food from their hosts, either by
feeding directly on tissues of the host, or by competing for
ingested food. Adult schistosomes live within the vascu-
lature of humans and rely on the blood cells and plasma
they ingest and dissolved solutes they derive across their
body surface, the tegument, for their nutrition. Schisto-
somes require host trace elements, notably iron, which is
used as a co-factor in many biological reactions. Iron is
especially important for schistosomes, for it has a
significant role in egg formation and embryogenesis. In
human tissues, iron predominates in the trivalent (ferric)
form; however, it is the divalent (ferrous) form that is used
as an essential co-factor for multiple biomolecules and
enzymes. In order to be acquired from the host
environment, the valency of iron must be modified to
render it suitable for transport across the parasite
membrane. This paper describes the molecular character-
isation of a schistosome molecule that is crucial for
bringing about this change in iron. Schistosoma japonicum
Cytb561 is the first ferric reductase characterised in any
parasitic helminth and emphasises the importance of iron,
and other divalent cations, in these organisms.
Cytochrome b561 Ferric Reductase from Schistosomes
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Genomic sequence and phylogenetic analysis of
Sjcytb561
The full-length cDNA of Sjcytb561 was cloned into the pCR4-
TOPO vector (Invitrogen) and chemically transformed in E. coli
TOP10 cells (Invitrogen) according to the manufacturer’s guide-
lines. Colonies were screened by colony PCR using a combination
of vector and insert primers. Plasmid mini-preps were prepared
(Qiagen) and the sequence verified from plasmids using M13F and
M13R vector primers and Big Dye sequencing chemistry (ABI) on
an ABI automated DNA sequencer. The consensus sequence was
compared with those already deposited in GenBank and the dbEST
databases using the BLAST algorithm on the NCBI server.
Topological data were obtained using the TMPRED server
(http://www.ch.embnet.org/software/TMPRED_form.html) and
the SignalP server (http://www.cbs.dtu.dk/services/SignalP/) was
used to predict the presence of signal peptide cleavage sites. Multiple
sequences were aligned using the Clustal W 1.8 algorithm on the
EBI server (http://www.ebi.ac.uk/Tools/clustalw2/index.html). A
phylogenetic tree was constructed using MEGAv3.0 software for
Molecular Evolutionary Genetics Anaylsis [37] to compare S.
japonicum and S. mansoni DMT1 sequences with homologous protein
sequences identified from the public databases by BLAST searches.
A minimum evolution phylogenetic tree was constructed using the
JTT substitution model, with uniform rates among sites being
assumed. The dataset was bootstrapped 1000 times, with the
resulting values shown on branches of the midpoint-rooted tree.
The Sjcytb561 cDNA sequence was used to interrogate the recently
published genomic dataset for S. japonicum [31] to gain insight into
genomic organization of the molecule. Alignment between the
cDNA and genomic sequences was performed using SIM 4 [38],
(http://pbil.univ-lyon1.fr/), to identify exons and introns in the
gene sequence.
Generation of anti-Sjcytb561 serum
Rabbit antiserum was raised against a synthetic peptide
(CISGITEKNFFSKNY) corresponding to a region of the third
extracellular loop of Sjcytb561. The region was chosen due to its
extracellular location, its predicted immunogenicity (Invitrogen
PeptideSelect; http://peptideselect.invitrogen.com/peptide/) and
its lack of homology to mammalian b561 homologues, thereby
reducing cross-reactivity with host tissues in the immunocyto-
chemistry studies. The peptide was commercially synthesised and
conjugated to Keyhole Limpet Hemocyanin (KLH) as carrier
protein (Sigma). The Institute of Medical and Veterinary Science
(IMVS), Adelaide, South Australia prepared the antiserum in a
New Zealand White rabbit against the cytb561-KLH peptide
using a protocol of 4 immunisations of 2 mg at weekly intervals.
Freund’s Complete Adjuvant (FCA) was used for the first
immunisation and Freund’s Incomplete Adjuvant (FIA) for the
subsequent three immunisations. Serum was collected 2 weeks
after the fourth immunisation and control, pre-immune serum was
collected prior to commencement of the immunisation schedule.
Purification of Sjcytb561-peptide reactive antibodies
Cyanogen bromide-activated Sepharose 4B (GE Healthcare),
coupled with KLH, was used to deplete the anti-b561-KLH
peptide antiserum of KLH immunoreactive antibodies. Serum was
diluted at 1:1 with PBS pH 7.4, added to the Sepharose 4B and
rotated end over end, at 4uC over night, to allow efficient binding
of KLH-specific antibodies. The flow through was collected to
obtain purified anti-cytb561 peptide antibodies. Antibodies
showing specific immunoreactivity against KLH were eluted from
the column using 100 mM glycine, pH 2.5, then equilibrated by
adding 1/10 volume of Tris-HCl, pH 8.0. Specificity of the anti-
cytb561 and KLH reactive antibodies was confirmed by dot and
Western blot analysis of a detergent-solubilized membrane extracts
of S. japonicum (see below) and KLH solution.
Western blot analysis of Sjcytb561
A protein extract from the tegument was prepared following
methods of van Balkom and colleagues [39]. Five mg of adult
parasite extracts (either tegument or ‘stripped’) and commercial
KLH (Sigma) were separated by gel electrophoresis on a 12% (w/
v) SDS-PAGE gel at 200 V for 1 hour at room temperature (RT)
and then transferred to nitrocellulose membrane at 200 mA for
1 hour at RT. The membrane was blocked for 1 hour at RT in
6% (v/v) skim milk powder diluted in PBS-T. All washes were
carried out in PBS-T. The membrane was incubated with primary
SjCytb561 antiserum a diluted at 1:100,000. A pre-immune serum
was used at equivalent dilutions for the negative control. In
addition anti-KLH specific antibodies were used as a control. After
incubation with the primary serum, the membrane was washed for
15 minutes in PBS-T and incubated with horseradish peroxidase-
conjugated goat anti-rabbit IgG (1:2000, BioRad) for 1 hour at
RT. The membrane was washed a further 3 times (5 minutes each)
in PBS-T and then developed with chemiluminescence (ECL Plus,
Amersham).
Immunolocalisation of Sjcytb561
Freshly perfused, unfixed adult S. japonicum worms were
embedded in Tissue-Tek Optimal Cutting Temperature (OCT)
compound (ProSciTech) and snap-frozen on dry ice. The block
was then cryostat-sectioned at a thickness of 7.0 mm and mounted
onto Superfrost slides. Sections were labeled using an indirect
immunofluorescence labelling protocol, whereby sections were
initially blocked for 1 hour at room temperature (RT) in 2% (w/v)
skim milk powder in PBS-Tween 20 (0.5%) (PBS-T), washed 3
times (5 minutes each) with PBS-T, and incubated with Sjcytb561
antisera at a 1:1000 dilution. Sections were also incubated with
pre-immune serum acting as a negative control. After washing,
sections were incubated with goat anti-rabbit IgG secondary
antibody conjugated to Cy3 fluorophore (Jackson ImmunoRe-
search Laboratories) at a 1:500 dilution. After 3 further washes
with PBS-T, slides were air-dried briefly and sections were
mounted in Vectorshield mounting medium (Vector Labs) that
contained a 49, 6-diamidino-2-phenylindole (DAPI) counterstain.
Sections were examined and photographed using a Leica DM IRB
fluorescence microscope equipped with a Leica DC 500 digital
camera.
Immuno-electron microscopy
Freshly perfused adult worms were fixed in 4% (v/v)
paraformaldehyde and 0.1% glutaraldehyde in 0.1 M phosphate
buffer for 1 hour. Worms were then dehydrated in ethanol and
infiltrated and embedded in LR White resin (ProSciTech) blocks.
The blocks were sectioned on an ultramicrotome (Leica EM UC6).
Sections were washed for 365 minutes in PBS, then blocked for 15
minutes in a blocking buffer consisting of 200 mL 10% (w/v)
bovine serum albumin (BSA), 200 mL 10% (w/v) fibroblast surface
glycoprotein (FSG), 1 mL 200 mM glycine, 2 mL phosphate
buffered saline (PBS) and made up to 10 mL with ultra high
quality (UHQ) water. Sections were then incubated in primary
antibody, either anti-Sjcytb561 or anti-KLH, for 30 minutes.
Primary antibodies were diluted 1:75 in blocking buffer and the
negative control was blocking buffer only. Grids were washed in
blocking buffer for 465 min and incubated in Protein A
conjugated to 10 nm colloidal gold particles (Aurion Immuno
Cytochrome b561 Ferric Reductase from Schistosomes
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Gold Reagents & Accessories) for 30 minutes at a 1:100 dilution.
Subsequently, sections were rinsed with 465 minute washes in
PBS and 462 minutes washes in UHQ water. Sections were
contrasted using uranyl acetate (1 minute) and lead citrate (30
seconds) and viewed using a JEM 1011 transmission electron
microscope operating at 80 kv and equipped with digital camera
system.
Functional expression of Sjcytb561 in yeast
Yeast strains S288C wildtype (MATa ura3-52 leu2-1) and
mutant S288CDfre1Dfre2 (MATa fre1:URA3 fre2:HISG leu2-1)
used in the assays were a gift from Professor Jerry Kaplan
(University of Utah, USA). Full-length Sjcytb561 cDNA was
amplified by PCR from adult worms and cloned into the pESC-
Leu vector (Stratagene). Yeast genomic DNA was obtained from
the S288C wildtype strain using Prepman Ultra Sample
Preparation Reagent (Applied Biosystems) according to the
manufacturer’s instructions. The resulting template was used to
amplify the Saccharomyces cerevisiae fre1 gene (GenBank accession
no. M86908), which was cloned into pESC-Leu as a positive
control. The clones were transformed into the S288CDfre1Dfre2
cells according to the manufacturer’s (Stratagene) protocol. The
transformed yeast cells were grown in SD dropout medium lacking
Leucine (SD-Leu). Expression was induced by transferring to
dropout medium containing galactose rather than dextrose (SG-
Leu).
Ferrireductase assays were carried out as described [28]. Briefly,
for the plate assay, low iron plates were made (SG-Leu minimal
medium, 2% (w/v) agarose, 50 mM Fe3+- ethylenediaminetetra-
acetic acid (EDTA). Fifty mM bathophenanthroline disulphonate,
(BPS, Sigma), a ferrous iron chelator, was added to remove any
residual ferrous iron from the plates. Transformed yeast were
grown overnight in liquid culture medium. Cells were grown until
the culture reached an OD600 of 0.8. Cells were then centrifuged,
washed twice with double distilled water. Five mL of cells were
plated at different concentrations and grown for 3 days at 30uC.
For the cell-surface ferrireductase assays, cells were grown,
collected and washed as per the plate assays, but were resuspended
in assay buffer (5% (w/v) glucose, 0.05 M sodium citrate, pH 6.5).
For the ferricyanide (FeCN) reductase assays, cells were added to
assay buffer, with FeCN to a final concentration of 0.356 mM.
The absorbance change was monitored for 5 min at 420 nm and
the ferricyanide reduction rates were calculated using the
established extinction coefficient of 1.02 mM21cm21 [28]. For
Fe3+-EDTA reductase assays, cells were added to assay buffer
containing 1 mM ferrozine and 250 mM Fe3+-EDTA as substrate.
Cells were incubated with shaking at 30uC. Over a time course,
1 mL of cells was removed, centrifuged for 20 seconds and the
absorbance of the supernatant measured at 562 nm. Blanks
containing assay buffer and ferrozine, but no cells, were incubated
at the same time, and the corresponding readings were subtracted
from each sample time point. The previously established
extinction co-efficient for the formation of ferrozine-ferrous iron
complex of 27.9 mM21cm21 was used in the activity calculations
[28].
Results
Identification of a cytochrome b561 in S. japonicum
Schistosoma japonicum datasets were searched by BLAST to
identify homologues of known ferric reductase proteins from other
organisms. This search revealed an EST with homology to the
cytochrome b561 family of proteins (Genbank, AY816000). Using
RACE PCR, the full-length cDNA was obtained, sequenced and
revealed a 1645 bp coding region. The translated sequence
encoded a 243 amino acid protein (Fig. 1A–B), with a predicted
molecular mass of 26.9 kDa.
In silico analysis of the Sjcytb561 sequence
The recent release of the S. japonicum genome [31] allowed us to
compare the sequence we confirmed for Sjcytb561 with the
putative in silico predicted sequence from the genome project.
Using BLAST function against the sequences in the S. japonicum
genome project (GeneDB_Sjaponicum_Gene.v4.0), we identified
the region of the genome in which the gene is located. BLAST
analysis of the genomic contigs (sjr2_contig.fas) identified a region
designated as: .gnl|lsbi|CNUS0000126016.1 (Schistosoma japoni-
cum isolate Anhui (wildtype) SJC_C017791, Length = 24880, Bit
Score = 402 E value = e-110, Identities = 203/203 (100%)) as the
genomic site of Sjcytb561. Using the program Sim 4, we aligned
cDNA sequence to the contiguous genomic sequence previously
identified by BLAST. This resulted in the identification of 5 exons
(Fig. 1C).
Analysis of the translated nucleotide sequence revealed the
presence of a signal peptide. The predicted topology of the
putative protein contained six transmembrane spanning regions,
four of which formed the ‘core domain’ identifiable in the
cytochrome b561 family of proteins [15]. In addition to these six
transmembrane helices, the predicted peptide of S. japonicum
contains four completely conserved histidine residues (thought to
co-ordinate two heme centers) (Fig. 2) and predicted substrate
binding sites (Fig. 2). Despite these completely conserved structural
features, the cytb561 sequences exhibit relatively low homology
both within and among species (Fig. 2). The S. japonicum sequence
shared between 30 and 45% homology with other cytb561 family
members (identity with human Dcytb, NP_079119 was 38%; with
that of Arabidopsis [GenBank accession no. CAA18169], 31%; and
with Xenopus cytb561 [AAA65644], 44%). A homologous sequence
(Smp 136400) was also identified in the S. mansoni GeneDB, which
is a first pass annotation of the S. mansoni genome assembly, with
85% identity to the S. japonicum sequence (http://www.genedb.
org/genedb/smansoni/).
Minimum evolution phylogenetic analysis (Fig. 1D) showed the
schistosome sequence grouped most closely with that of the
freeliving turbellarian, Dugesia japonica, another member of the
Phylum Platyhelminthes. However, this grouping was not
supported, having a low bootstrap value. There was a distinct
clustering of mammalian duodenal cytochromes (Human,
NP_079119 and Mouse AAK50909) relative to other mammalian
cytb561 proteins. There are also distinct branches representing the
type 1 and type 2 mammalian cytochromes b561. Type 1 cytb561
members include neuroendocrine expressed proteins, such as
chromaffin granule cytochromes, which are present in the adrenal
medulla (Human, P49447, Mouse, Q60720). Type 2 mammalian
cytsb561, found in humans and the mouse, are termed
‘ubiquitious’ cytochromes as they are more widely expressed
(Human, NP_705839, Mouse, Q6P1H1) [24]. Individual func-
tions of the proteins contained in this tree have not all been
experimentally assessed and confirmed, particularly those from
invertebrates.
Stage specific expression of Sjcytb561
Quantitative analyses of expression of SjCytb561 in different
stages of the life cycle (Fig. 3), showed highest mRNA expression in
adult (7-week-old) males, with less expression in developing (4-
week-old) males and females. Expression in the 7-week-old females
appeared to diminish compared with 4-week-old females. Lower
expression levels were evident in the schistosomula and cercariae.
Cytochrome b561 Ferric Reductase from Schistosomes
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Figure 1. Bioinformatic and phylogenetic sequence analysis of SjCytb561. A. Schematic diagram of the SjCytb561 cDNA and protein
sequence. The protein sequence contains a predicted signal peptide (SP) and the four conserved histidine residues (H) shown in red. B. Schematic
representation of the predicted membrane topology and orientation of full length SjCytb561. The 59 N-terminal signal peptide sequence is shown in
red and the conserved histidine residues that bind two heme molecules and confer tertiary structure are coloured yellow. The region depicted in
orange indicates the location of the peptide sequence that was used for antibody production. C. Genomic organization of Sjcytb561. The cDNA
structure is presented at the top with exon sequence positions shown. Below is the corresponding cDNA structure with exons shown as boxes and
intermediate intron regions shown as solid lines; again relative sequence positions are noted. D. Minimum evolution phylogenetic tree inferred from
amino acid sequences of cytochrome b561 genes from a variety of organisms. Species name and published accession numbers are shown for each
sequence. Bootstrap values (1000 resamplings) are shown to the left of the relevant nodes.
doi:10.1371/journal.pntd.0000884.g001
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Western blot analysis and immunolocalisation of native
Sjcytb561
Western blot analysis (Fig. 4) of adult schistosome membrane
extracts using KLH-depleted anti-Sjcytb561 sera showed a tight
band at approximately 30 kDa (Fig. 4, lane 2), which is in
accordance with the predicted molecular mass of 26.8 kDa. No
band was observed with pre-immune sera probed against the
tegument exacts (Fig. 4, lane 4). Anti-SjCytb561 sera probed
against commercial KLH did not elicit a reaction, suggesting
KLH-cross-reactivity was not a problem (Fig. 4, lane 3). Further,
anti-KLH antibodies did not show reactivity against the
schistosome tegument extracts (Fig. 4, lane 6).
Sections of adult worms probed with pre-immune rabbit serum
and secondary serum conjugated to Cy3 did not show any
significant fluorescence (Fig. 5A), nor did the secondary antibody
only sections (not shown). Sections probed with anti-Sjcytb561
antibodies showed strong labelling on the distal cytoplasm of the
outer tegument (Fig. 5B and 5C) and more diffuse reactivity over
the underlying parenchyma. These results suggest a tegumental
role for cytochrome b561 in S. japonicum.
Electron micrographs of adult tegument probed with anti-
SjCytb561 serum (Fig. 6A and 6B) showed the presence of gold
probes in the apical membrane complex. Labelling with anti-KLH
serum and with the negative controls did not show labelling of gold
probes in this region.
Functional expression of Sjcytb561 in a yeast mutant
model
In light of the discovery that some cytochromes b651s exhibit
ferric reductase capability [26,27,28,29,40], the S. japonicum
cytochrome b561 was expressed in a yeast model deficient in
ferric reductase activity. Fre1 and Fre2 are yeast ferrireductases
Figure 2. Multiple sequence alignment (ClustalW) of the deduced amino acid sequence of SjCytb561 with sequences in other taxa
belonging to the Cytb561 family. Sequences included are: Human (GenBank accession no: NP_079119) and mouse (AAK50909) Dcytb, and other
Cytb561s from human (P49447), mouse (Q60720), Anopheles gambiae (EEA11195), Xenopus laevis (AAA65644), Caenorhabditis elegans (CAA81603) and
Arabidopsis thaliana 1 (CAA18169) and 2 (BAB10153). Putative transmembrane regions are spanned by a black line and labelled TM. The conserved
histidine residues are indicated by the blue circles and the substrate-binding regions are shown in red boxes. The S. japonicum sequence used for the
construction of a synthetic peptide for antiserum production is shown underlined in yellow.
doi:10.1371/journal.pntd.0000884.g002
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that are responsible for almost all ferric reductase activity at the
plasma membrane [6,41,42]. The fre1Dfre2D mutant yeast grows
poorly in iron-restricted conditions, but can be rescued by
complementation with the Fre1 gene. The Sjcytb561 protein
was expressed in this mutant model to determine whether it
exhibits ferric reductase activity. Empty vector was used as the
negative control in these experiments. Growth of the transformed
yeast on solid phase media showed that the presence of the
Sjcytb561 protein restored growth equal to that of the Fre1
positive control, indicating the molecule has ferric-reductase
activity (Fig. 7A).
To further investigate the kinetics of ferric reductase activity
occurring in the rescued cells, assays were performed on intact
yeast cells in liquid culture (Fig. 7B). Ascorbate is the predicted and
commonly accepted electron donor for cyts-b561 under physio-
logical conditions [43,44], so cultures were also tested in the
presence or absence of ascorbate to determine its contribution to
activity. The cells transformed with empty vector did not exhibit
significant ferric reductase activity. The Fre1-transformed cells
had a high level of ferric reductase activity that was independent of
the presence or absence of ascorbate. The Sjcytb561 transformed
cells also exhibited a high level of ferric reductase activity, which
was greatly enhanced by the addition of ascorbate. There was also
a difference seen in the form of iron substrates used in the
experiments, with FeCN a more efficient substrate.
Discussion
All organisms that require iron have at least one ferrous iron
transport system, and often many more than one. The limited
availability of ferrous iron in many environments has necessitated
the evolution of a range of ferric reductases to allow ferrous iron
uptake to occur [2,8]. Cytochrome b561 has been identified in a
large number of phylogenetically distant taxa and many species
contain more than one cytb561 [24]. This family of proteins has
long been known to play a role in ascorbate regeneration and
electron transfer, but its role as a reducer of ferric iron has only
been recognised recently [26,27,28,29], largely through studies of
mammalian duodenal cytochrome b [10,27,40,45,46].
Sjcytb561 is the first of this family of proteins identified from
any parasitic platyhelminth or nematode, which is surprising as the
protein is found ubiquitously in the plant and animal kingdoms
[24]. The S. japonicum cytb561 has all the structural hallmarks of
the family, including the six transmembrane spanning regions,
four completely conserved histidine residues and the conserved
substrate binding sites (Fig. 2). However, unlike other organisms
Figure 3. Expression of SjCytb561 in different S. japonicum life cycle stages. Abbreviations: M4, male 4 weeks post infection (wpi); F4, females
4 wpi; M7, male 7 wpi. F7, females, 7 wpi; Egg, eggs; Mira, miracidia; Sporo, sporocyts; Somula, - lung-stage schistosomula; Cerc, cercariae.
doi:10.1371/journal.pntd.0000884.g003
Figure 4. Western blot analysis of S. japonicum Cytb561. Lanes 1
to 3 were probed with, anti-SjCytb561 serum. Lane 1 probed against an
adult worm ‘stripped’ extract shows no reactivity. Lane 2, probed
against adult tegument extract shows a band at approximately 30 kDa.
Lane 3 was probed against 5 mg of commercial KLH protein, and shows
no reactivity. Lane 4 is pre-immune serum probed against adult worm
tegumental extract and shows no reactivity. Lanes 5 to 7 were probed
with anti-KLH antibodies. Lane 5 is against ‘stripped’ worm extract and
shows a number of bands. Lane 6 shows tegument extract and no
reactivity. Lane 7 contained 5 mg of KLH and shows intense reactivity
against the anti-KLH sera.
doi:10.1371/journal.pntd.0000884.g004
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which possess multiple Cytsb561, S. japonicum and S. mansoni
appear to have only one Cytb561 transcript in their respective
genomes. A study by Tsubaki and colleagues [15] aimed to predict
the function of all known members of the cytochrome b561 family
based on protein sequence motif analyses in the conserved binding
regions. This study predicted that only a subset of the family would
have ferric reductase function. Notably, the Sjcytb561 protein
identified here was predicted to belong to the group with ferric
reductase potential [15]. The yeast rescue assay presented here
provides the first evidence of ferric reductase activity in a non-
mammalian metazoan cytochrome b561.
Yeast is one of the best characterised model eukaryotes for iron
metabolism and iron transport. Fre1 and Fre2 are responsible for
almost all of the ferric reductase activity in yeast cells that if
knocked out result in a significant defect in growth
[3,6,41,42,47,48,49]. Functional assays in the yeast Dfre1Dfre2
mutant demonstrated the ability of Sjcytb561 to reduce ferrous
iron and, thereby, restore iron uptake and normal growth (Fig. 7).
This mechanism for the S. japonicum Cytb561 appears to be
ascorbate-dependent, as there was a significant increase in
reductase activity with the addition of ascorbate. Fre1 transformed
yeast are not affected in the same manner by the addition of
ascorbate, as Fre1 is a NADPH-dependent reductase [41]. Yeast
are unable to synthesise ascorbate but they do synthesise a
homologue called erythroascorbate. The low ferric reductase
activity that was observed without the addition of ascorbate may
suggest that erythroascorbate, or some other reductant, in the
yeast cells may be able to function as the electron donor in this
Figure 5. Immunolocalisation of SjCytb561 in S. japonicum male adult worms using primary rabbit sera and secondary sera
conjugated to Cy3, and DAPI counterstain. Panel A shows an adult male worm probed with pre-immune sera. Panels B and C show reactivity
over the tegument and basally to the tegumental matrix after localisation with anti-SjCytb561 serum.
doi:10.1371/journal.pntd.0000884.g005
Figure 6. Electron micrographs of S. japonicum male adult worm tegument showing immunogold labelling of SjCytb561 and KLH.
Panels A and B were labelled with anti-SjCytb561 sera and show gold probes (examples indicated by arrows) over the apical membrane complex
(AMC) of the tegument. Panel C was labelled using anti-KLH sera and does not show labelling in the AMC.
doi:10.1371/journal.pntd.0000884.g006
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Figure 7. SjCytb561 can rescue the growth defect of Dfre1Dfre2 mutant yeast cells. A. Growth on solid phase media. Five microlitres of
cells at different concentrations were plated on low iron media containing 50 mM Fe3+-EDTA as iron substrate. Fifty mM BPS (iron chelator) was also
added to remove any free ferrous iron. Empty vector was transformed into wildtype and mutant cells to enable growth of SG-Leu media. B. Ferric
reductase activity of SjCytb561 in intact yeast cells. Vectors were transformed into Dfre1Dfre2 mutant cells to measure ferric reductase activity using
FeCN (A) and Fe3+-EDTA (B) as ferric iron substrates, in the presence or absence of ascorbate (ASC).
doi:10.1371/journal.pntd.0000884.g007
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reaction [43,44]. The ability to synthesise ascorbate has been lost a
number of times in evolution, most notably in humans, and it is
unknown if schistosomes are able to synthesise their own ascorbate
or, if indeed, it too must be scavenged from the host [50,51].
The localisation of Sjcytb561 to the tegument (Fig. 5 and 6) is
consistent with that of schistosome DMT1, a known ferrous iron
transporter [23]. It is possible that these two proteins act together
to take up iron from the host, although the presence of other ferric
reductases at this site cannot be excluded. Indeed, the lack of
phenotype observed in mammalian Dcytb knockout studies makes
it likely that there are other ferric reductases able to perform this
role [54]. Neither the schistosome DMT1 nor this newly identified
cytochrome b561 have been identified in proteomic studies of the
schistosome tegument [39,52,53]. Iron homeostasis proteins of
eukaryotes show transcriptional changes in response to cellular
iron levels, whereby expression of proteins involved in acquisition
and utilization of iron are increased in response to iron deficiency
[54]. Mechanisms also exist to change the sub-cellular localisation
of iron transport proteins, a process that is considered the ‘first
line’ response of cells after changes in iron levels. It is often
necessary to induce iron-starvation conditions to achieve signifi-
cant up-regulation for the analysis of these proteins [54]. Given
that the previous proteomic studies [39,52,53] were conducted on
parasites obtained from iron-replete hosts it is possible that the
schistosome iron transport molecules are, in fact, present at very
low levels and combined with changes in sub-cellular localisation
were not identified in these analyses. Future proteomic studies
could be conducted on parasites cultured under iron-deficient
conditions to confirm this. Mammalian duodenal cytochrome b
has been demonstrated to reduce copper in vitro and it is possible
that cytochromes b561 may play a more general role in metal iron
uptake [55]. The molecular mass of iron is similar to metals such
as copper, manganese, zinc and cobalt and most other ferrous iron
transport systems can also take up these and other transition
metals [2]. Notably, a transporter for copper has been identified in
proteomic studies of schistosome tegument extracts [52].
The high expression levels for Sjcytb561 in adult males
complemented the tegument localisation data. In vivo, the male
worm surrounds the female schistosome, holding her in his
gynaecophoral canal. The tegument of the male is in constant
contact with host serum molecules, and has a larger surface area
than that of the female [56]. Hence, Sjcytb561 would be expected
to be highly expressed at this site in adult males. The reduction of
transcript expression from the 4-week females to the 7-week
females is logical since at 7 weeks more genes would be
upregulated for egg production, rather than purely for growth
and nutrition needs. The question of iron utilisation in egg
production by females, be it for egg shell formation or for use by
the developing miracidia within the egg [17,18], remains
undefined. However, the relatively low SjCytb561 ferric reductase
expression levels in the miracidia and eggs of S. japonicum is
noteworthy in that it suggests that if iron is being liberated from
vitelline cells by the developing embryo, it is unlikely to involve
cytochrome b561 reductase-mediated release of iron.
It has been postulated that ferric reductases, by decreasing the
affinity of biological carriers for iron, may play a role in the
removal of iron from chelators [57]. In the case of schistosomes,
this may mean aiding in the release of iron from the abundant host
serum iron glycoprotein, transferrin. It has also been hypothesised
that using ferric reductase coupled with iron uptake mechanisms
may allow parasites and other pathogens to survive in a more
diverse range of hosts and tissues, than organisms restricted to
specific receptor-mediated iron uptake [13] [58]. In the absence of
any clear research regarding haem uptake and usage in
schistosomes it can be postulated that this surface mediated iron
uptake mechanism is at least used to supplement the adult worms
iron needs.
S. japonicum cytb561 is the first ferric reductase identified in any
parasitic helminth and emphasises the importance of iron and
other divalent cations in this group of important parasites. Further
understanding of the mechanisms of metal uptake and utilization
in schistosomes may uncover novel drug and vaccine targets for
controlling schistosomiasis.
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